Abstract

e21029Background: The programmed death (PD-1) inhibitor pembrolizumab has recently been approved for treatment of advanced melanoma patients (p), based on a significant improvement in terms of surv...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Yang Meng ... Andrew Walker
The European journal of health economics : HEPAC : health economics in prevention and care | VOL. 19
Yang Meng, et. al.Yang Meng ... Andrew Walker
09 Mar 2018
Adjuvant Therapy for Resected Stage III Melanoma Patients: High-Dose Interferon-Alpha versus Ipilimumab Combined with Kinases Inhibitors
Ettore Minutilli ... Claudio Feliciani
Tumori | VOL. 98
Ettore Minutilli, et. al.Ettore Minutilli ... Claudio Feliciani
01 Mar 2012
Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.
Ettore Minutilli ... Claudio Feliciani
Tumori | VOL. 98
Ettore Minutilli, et. al.Ettore Minutilli ... Claudio Feliciani
29 Jan 2018
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions
Paul Aliu ... Ramona Reichenbach
JAMA health forum | VOL. 3
Paul Aliu, et. al.Paul Aliu ... Ramona Reichenbach
15 Apr 2022
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss.
Margaret Cupit-Link
Journal of Clinical Oncology | VOL. -
Margaret Cupit-LinkMargaret Cupit-Link
23 Jul 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.
Rafal Dziadziuszko ... Witold Rzyman
Journal of Clinical Oncology | VOL. -
Rafal Dziadziuszko, et. al.Rafal Dziadziuszko ... Witold Rzyman
23 Jul 2024
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update.
Megan E Daly ...
Journal of Clinical Oncology | VOL. -
Megan E Daly, et. al.Megan E Daly ...
23 Jul 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
Connor Lynch ... Ralph R Weichselbaum
Journal of Clinical Oncology | VOL. -
Connor Lynch, et. al.Connor Lynch ... Ralph R Weichselbaum
22 Jul 2024
View more papers